The Bimatoprost Ocular Insert is intended to provide sustained delivery of bimatoprost to the
ocular surface to lower the intraocular pressure (IOP) in patients with open-angle glaucoma
or ocular hypertension.
This study will evaluate the pharmacokinetic aspects of the Bimatoprost Ocular Insert in
healthy (non-glaucoma) subjects.